LEADS BIOLABS-B: Xiaoqiang Kang Disposes of Shares, Long Position Falls to 14.93%

HK Disclosure09-21

On September 15, 2026, Xiaoqiang Kang, through Lizi Partnership (a controlled entity and share incentive platform), disposed of 859,100 shares of LEADS BIOLABS-B (09887) on the SEHK open market at an average of HKD 63.6904 per share, involving about HKD 54.72 million. The sale was executed on behalf of employees as per their instructions; Kang himself did not reduce his personal holding. This was an on-exchange active trade, a direct dealing in the secondary market.

Prior to the disposal, Xiaoqiang Kang's long position in LEADS BIOLABS-B was 30.38 million shares, representing 15.37%; following the disposal, the holding decreased to 29.52 million shares, with the long position ratio falling to 14.93%.

This involves related parties: Lai Shoupeng.

Source: Hong Kong Exchanges and Clearing Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment